Angoor Pharmaceuticals Private Limited
About Angoor Pharmaceuticals Private Limited
Data last updated:
Angoor Pharmaceuticals Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 18 April 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24233KA2011PTC058179. Its GSTIN is 29AAJCA5571E1ZJ (Karnataka).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sumitra Agiwal and Prahalad Rai Agiwal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat 2091 Sobha Indraprastha Minerva Mill Compound Opp. Sujatha Theatre Rajajinagar, Bangalore, Karnataka, India – 560023.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Angoor Pharmaceuticals Private Limited's registered office is in Bangalore, Karnataka. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressFlat 2091 Sobha Indraprastha Minerva Mill Compound Opp. Sujatha Theatre Rajajinagar, Bangalore, Karnataka, India – 560023
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of Angoor Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Angoor Pharmaceuticals Private Limited
FY 2025 filings availableAngoor Pharmaceuticals Private Limited reported revenue of ₹16 (down 100% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 90% over five years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Angoor Pharmaceuticals Private Limited, buy the company report.
Board of directors of Angoor Pharmaceuticals Private Limited
Angoor Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sumitra Agiwal | Director | 31 Aug 2012 | 14 Years 2 Months | Current |
| Prahalad Rai Agiwal | Director | 18 Apr 2011 | 15 Years 6 Months | Current |
Auditor
Angoor Pharmaceuticals Private Limited is audited by GRV and PK for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GRV and PK | FY 2017 | 008099S |
Shareholding
The shareholding of Angoor Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Angoor Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Angoor Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Angoor Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Angoor Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAJCA5571E1ZJ | Karnataka | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Angoor Pharmaceuticals Private Limited, buy the company report.
Recent activity
Angoor Pharmaceuticals Private Limited has 5 board changes on record since 2011: 2 appointments and 3 cessations. The latest: Sumitra Agiwal ceased to be Additional Director on 29 Sep 2012.
Frequently asked questions
Angoor Pharmaceuticals is an active private limited company based in Bangalore, Karnataka, India. The company works in other wholesale, within the trading industry. It was incorporated on 18 April 2011 (15+ years old) and is registered under CIN U24233KA2011PTC058179.
Angoor Pharmaceuticals has 2 current directors:
- Sumitra Agiwal - Director
- Prahalad Rai Agiwal - Director
The latest financial statements of Angoor Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Angoor Pharmaceuticals is 29AAJCA5571E1ZJ, registered in Karnataka.
The CIN (Corporate Identification Number) of Angoor Pharmaceuticals is U24233KA2011PTC058179. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Angoor Pharmaceuticals was incorporated on 18 April 2011, making it 15+ years old. It is registered with the Registrar of Companies, Bangalore.
Sumitra Agiwal ceased to be Additional Director on 29 Sep 2012. Nihar Ranjan Samantara ceased to be Director on 03 Sep 2012. Sumitra Agiwal was appointed as Director on 31 Aug 2012. Angoor Pharmaceuticals has 5 board changes on record in total.
The registered office of Angoor Pharmaceuticals is at Flat 2091 Sobha Indraprastha Minerva Mill Compound Opp. Sujatha Theatre Rajajinagar, Bangalore, Karnataka, India – 560023.
Angoor Pharmaceuticals operates in the trading industry, in the other wholesale segment.
The compliance status of Angoor Pharmaceuticals is compliant as of 11 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
